No Gain for Milrinone Over Dobutamine in Cardiogenic Shock
A head-to-head randomized comparison of milrinone and dobutamine — the most ancient inotropes in cardiogenic shock treatment in North America — failed to seek out a important advantage for one agent over the other. Patients treated with milrinone and dobutamine…